Invention Grant
- Patent Title: Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation
-
Application No.: US17350497Application Date: 2021-06-17
-
Publication No.: US12077604B2Publication Date: 2024-09-03
- Inventor: Sumayah Jamal
- Applicant: ENB Therapeutics Inc.
- Applicant Address: US NY New York
- Assignee: ENB Therapeutics, Inc.
- Current Assignee: ENB Therapeutics, Inc.
- Current Assignee Address: US NY New York
- Agency: Goodwin Procter LLP
- Main IPC: C07K5/02
- IPC: C07K5/02 ; A61K38/17 ; A61P35/00 ; C07B59/00 ; C07K5/083
Abstract:
Disclosed herein are deuterated compounds, pharmaceutical compositions thereof, and methods for treating ETBR-related cancers. Also disclosed herein is a delivery system for the controlled, systemic release of at least one deuterated ETBR antagonist, optionally in conjunction with an additional anti-oncologic agent.
Public/Granted literature
- US20210309694A1 DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION Public/Granted day:2021-10-07
Information query
